77380329
Jan 25, 2008
SCIELE PHARMA INC.
Subscribe
Pharmaceutical Products, in the Form of an Extended Release Oral Dosage for the Treatment of Attention Deficit Hyperactivity Disorders and Other Disorders Characterized by Excessive Autonomic Hyperactivity